SYNJ2BP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.367400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.910800E-01
Normal-vs-Stage2
7.044200E-01
Normal-vs-Stage3
5.760000E-02
Normal-vs-Stage4
4.487400E-01
Stage1-vs-Stage2
2.346200E-01
Stage1-vs-Stage3
3.745700E-02
Stage1-vs-Stage4
5.062200E-01
Stage2-vs-Stage3
4.432100E-02
Stage2-vs-Stage4
3.277600E-02
Stage3-vs-Stage4
6.746000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.548800E-01
Normal-vs-AfricanAmerican
8.722400E-01
Normal-vs-Asian
4.087200E-01
Caucasian-vs-AfricanAmerican
9.885400E-01
Caucasian-vs-Asian
2.694600E-01
AfricanAmerican-vs-Asian
4.523800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.360600E-01
Normal-vs-Female
8.439200E-01
Male-vs-Female
8.928800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.168200E-01
Normal-vs-Age(41-60Yrs)
7.671000E-01
Normal-vs-Age(61-80Yrs)
6.237400E-01
Normal-vs-Age(81-100Yrs)
5.851600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.579400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.254200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.937600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.898700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.378220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.211000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.805000E-01
Normal-vs-Daily Drinker
5.116000E-01
Normal-vs-Weekly Drinker
4.390600E-01
Normal-vs-Occasional Drinker
8.669600E-01
Normal-vs-Social Drinker
6.444800E-01
Non Drinker-vs-Daily Drinker
9.616400E-01
Non Drinker-vs-Weekly Drinker
7.295800E-01
Non Drinker-vs-Occasional Drinker
4.921700E-02
Non Drinker-vs-Social Drinker
8.103900E-02
Daily Drinker-vs-Weekly Drinker
7.531200E-01
Daily Drinker-vs-Occasional Drinker
1.170760E-01
Daily Drinker-vs-Social Drinker
9.593900E-02
Weekly Drinker-vs-Occasional Drinker
9.526000E-02
Weekly Drinker-vs-Social Drinker
8.031600E-02
Occasional Drinker-vs-Social Drinker
4.291000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.030840E-01
Normal-vs-Grade 2
9.635300E-03
Normal-vs-Grade 3
1.630270E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.490600E-01
Grade 1-vs-Grade 3
3.348400E-01
Grade 1-vs-Grade 4
1.030840E-01
Grade 2-vs-Grade 3
7.757200E-01
Grade 2-vs-Grade 4
9.635300E-03
Grade 3-vs-Grade 4
1.630270E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.063600E-01
Normal-vs-NonDiabetic
8.163600E-01
Diabetic-vs-NonDiabetic
2.319800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.744000E-01
Normal-vs-NoPancreatitis
7.548800E-01
Pancreatitis-vs-NoPancreatitis
4.772000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.587400E-01
Normal-vs-N1
7.106200E-01
N0-vs-N1
2.598400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.537400E-01
Normal-vs-TP53-NonMutant
7.842800E-01
TP53-Mutant-vs-TP53-NonMutant
3.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
